Please use this identifier to cite or link to this item:
Title: Molecular diagnosis of an unconventional 5'splice site mutation causing congenital liver fibrosis
Authors: Muhammad Ridhwan Mohammad Muzaki
Keywords: DRNTU::Science
Issue Date: 2016
Abstract: Normally, disease-causing 5′ splice-site (5′ss) mutations disrupt Watson-Crick/wobble base pair(s) with U1 small nuclear RNA (snRNA) but some mutations do not. In this thesis, we investigated a T→C mutation in hemochromatosis (HFE) intron 2 which might break a possible non-canonical Ψ-U base pair in 5′ss recognition. This mutation occurs in cis with a c.193A→T HFE exon 2 mutation in a patient with hereditary hemochromatosis (HH). HFE exon 2 encodes for the protein domain that interacts with Transferrin receptor 1 (TFR1), so disrupting this interaction by removing this domain should cause hemochromatosis. To characterize the effects of these nucleotide substitutions on exon 2 inclusion, we constructed a HFE splicing minigene and introduced these mutations. After mammalian cell transfection, the splicing patterns were inferred by RT-PCR and gel electrophoresis. Surprisingly, the T→C mutation slightly enhanced exon 2 inclusion while the c.193A→T mutation caused significant exon 2 skipping. Thus, our findings have shown that the T→C mutation is not likely causing HH while the c.193A→T mutation contributes to HH by disrupting an exonic splicing enhancer (ESE) which induces exon skipping. As the c.193A→T mutation is generally only linked to mild hemochromatosis, further work is required to identify other HH-causing mutations in this patient.
Rights: Nanyang Technological University
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:SBS Student Reports (FYP/IA/PA/PI)

Files in This Item:
File Description SizeFormat 
Ridhwan FYP FINAL 250416.pdf
  Restricted Access
MAIN ARTICLE897.37 kBAdobe PDFView/Open

Page view(s)

Updated on Jun 23, 2021


Updated on Jun 23, 2021

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.